P. Watkins

Selection and characterization of acriflavine-induced mutants of Candida albicans

P. Watkins, P. Brandt, D. O. McClary, 2004, Antonie van Leeuwenhoek.

Low biotinidase activities in the sera of patients with impaired liver function: evidence that the liver is the source of serum biotinidase.

B. Wolf, G. S. Heard, P. Watkins, 1990, Clinica chimica acta; international journal of clinical chemistry.

Kinetic and immunochemical characterization of α-l-fucosidase from vertebrate livers

P. Watkins, J. Alhadeff, 1981 .

Cystic fibrosis serum alpha-l-fucosidase: confirmation of normal activity levels and normal kinetic and isoelectric focusing properties.

P. Watkins, J. Alhadeff, 1980, Clinica chimica acta; international journal of clinical chemistry.

Purification and characterization of altered cystic fibrosis liver α‐L‐fucosidase

H. Freeze, P. Watkins, J. Alhadeff, 1978 .

Neomycin production by Micromonospora species 69-683.

G. Wagman, M. Weinstein, J. Marquez, 1973, The Journal of antibiotics.

A New Actinomycin Complex Produced by a Micromonospora Species: Fermentation, Isolation, and Characterization

G. Wagman, M. Weinstein, J. Marquez, 1976, Antimicrobial Agents and Chemotherapy.

Dolichyl phosphate-mannosyltransferase and dolichyl phosphate-N-acetylglucosaminyltransferase activities in liver preparations from normal controls and patients with cystic fibrosis and diabetes mellitus.

P. Watkins, J. Alhadeff, 1983, Clinica chimica acta; international journal of clinical chemistry.

Differential Concanavalin A binding of cystic fibrosis and normal liver α-L-fucosidase

P. Watkins, J. Alhadeff, 1979 .